Division Amendment History - Australia New Zealand Food Standards Code - Standard 2.9.1 - Infant Formula Products - Amendment History

Amendment History

The Amendment History provides information about each amendment to the Standard. The information includes commencement or cessation information for relevant amendments.

These amendments are made under section 92 of the Food Standards Australia New Zealand Act 1991 unless otherwise indicated. Amendments do not have a specific date for cessation unless indicated as such.

About this compilation

This is a compilation of Standard 2.9.1 as in force on 30 October 2014 (up to Amendment No. 150). It includes any commenced amendment affecting the compilation to that date.

Prepared by Food Standards Australia New Zealand on 30 October 2014.

Uncommenced amendments or provisions ceasing to have effect

To assist stakeholders, the effect of any uncommenced amendments or provisions which will cease to have effect, may be reflected in the Standard as shaded boxed text with the relevant commencement or cessation date. These amendments will be reflected in a compilation registered on the Federal Register of Legislative Instruments including or omitting those amendments and provided in the Amendment History once the date is passed.

The following abbreviations may be used in the table below:

ad = added or inserted am = amended

exp = expired or ceased to have effect rep = repealed

rs = repealed and substituted

Standard 2.9.1 was published in the Commonwealth of Australia Gazette No. P 30 on 20 June 2002 as part of Amendment No. No. 60 (F2008B00798 – 19 December 2008) and has been amended as follows:

Clause affected	A’ment No.	FRLI registrationGazette	Commencement(Cessation)	How affected	Description of amendment
Purpose	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	am	Purpose relating to infant formula products.
Table of Provs	78	F2005L0124626 May 2005FSC2026 May 2005	26 May 2005	rs	New heading for clause 24.
Table of Provs	138	F2013L0005014 Jan 2013FSC8018 Jan 2013	18 Jan 2013	am	Amendment relating to the heading of clause 28.
Table of Provs	150	F2014L0142728 Oct 2014FSC9230 Oct 2014	30 Oct 2014	ad	Reference to clause 9A to reflect previous amendment.
1	124	F2011L014508 July 2011FSC6611July 2011	11 July 2011	am	Definition of ‘protein substitute’.
1(2)	101	F2008L0305814 Aug 2008FSC4314 Aug 2008	14 Aug 2008	rep	Editorial notes in the definitions.
1(2)	101	F2008L0305814 Aug 2008FSC4314 Aug 2008	14 Aug 2008	ad	Editorial note relating to infant formula product definitions after the subclause.
1(2)	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	rs	Subclause.
7	101	F2008L0305814 Aug 2008FSC4314 Aug 2008	14 Aug 2008	rep	Editorial note before the Table to clause 7..
7(1)(b)	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	ad	After ‘the total amount of the’ inserting ‘added and any naturally occurring’.
7(2)	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	ad	After ‘the total amount of the’ inserting ‘added and any naturally occurring’.
Table to clause 7	108	F2009L0206628 May 2009FSC5028 May 2009	28 May 2009	am	Column headings.
Table to clause 7	108	F2009L0206628 May 2009FSC5028 May 2009	28 May 2009	ad	Entry for lutein.
Table to clause 7	124	F2011L014508 July 2011FSC6611July 2011	11 July 2011	rs	Entries for adenosine 5′-monophosphate, cytidine 5′-monophosphate and uridine 5′-monophosphate.
9A	105	F2009L0007615 Jan 2009FSC4715 Jan 2009	15 Jan 2009	ad	New clause related to inulin-derived substances and galacto-oligosaccharides.
9A	142	F2013L0146530 July 2013FSC841 Aug 2013	1 Aug 2013	rs	‘Inulin-derived substances’ replaced with ‘inulin-type fructans’ and consequential amendment to the Table of Provisions.
16	101	F2008L0305814 Aug 2008FSC4314 Aug 2008	14 Aug 2008	ad	Editorial note after the clause relating to the Guideline at the end of this Standard.
16	142	F2013L0146530 July 2013FSC841 Aug 2013	1 Aug 2013	rs	‘Inulin-derived substances’ replaced with ‘inulin-type fructans’.
16(1)	105	F2009L0007615 Jan 2009FSC4715 Jan 2009	15 Jan 2009	rs	Consequential amendments related to inulin-derived substances and galacto-oligosaccharides.
16(2)(e)	124	F2011L014508 July 2011FSC6611July 2011	11 July 2011	rs	Clarification of the intent of the paragraph.
17	101	F2008L0305814 Aug 2008FSC4314 Aug 2008	14 Aug 2008	am	Editorial note after the clause.
20	105	F2009L0007615 Jan 2009FSC4715 Jan 2009	15 Jan 2009	rs	Consequential amendments related to inulin-derived substances and galacto-oligosaccharides.
20(1)(f)	124	F2011L014508 July 2011FSC6611July 2011	11 July 2011	rs	Clarification of the intent of the paragraph.
20(2)	124	F2011L014508 July 2011FSC6611July 2011	11 July 2011	rs	Clarification of the intent of the subparagraphs.
20(2)	142	F2013L0146530 July 2013FSC841 Aug 2013	1 Aug 2013	rs	‘Inulin-derived substances’ replaced with ‘inulin-type fructans’ and consequential amendment to the Table of Provisions.
22	72	F2008B0081924 Dec 2008FSC1420 May 2004	20 May 2004	rs	References for ‘cysteine’ amended to ‘cyst(e)ine’.
22(2)(a	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	rs	‘Cyst(e)ine & methionine’ replaced with ‘cysteine, cystine and methionine’ and related consequential amendments.
Table to clause 22	101	F2008L0305814 Aug 2008FSC4314 Aug 2008	14 Aug 2008	rep	Editorial note after the Table.
Table to clause 22	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	rs	‘Cyst(e)ine & methionine’ replaces with ‘cysteine, cystine and methionine’ and related consequential amendments.
Table to clause 22	141	F2013L0081121 May 2013FSC8323 May 2013	23 May 2013	rs	Entry for histidine.
23(a)	88	F2006L032705 Oct 2006FSC305 Oct 2006	5 Oct 2006	am	Reference to medium chain triglycerides.
23(d)	95	F2007L0470013 Dec 2007FSC3713 Dec 2007	13 Dec 2007	am	Long chain omega 3 and 6 series fatty acid ratio.
Table to clause 23	101	F2008L0305814 Aug 2008FSC4314 Aug 2008	14 Aug 2008	rep	Editorial notes.
Table to clause 23	124	F2011L014508 July 2011FSC6611July 2011	11 July 2011	rs	Editorial note after the Table arising from amendments to specifications in Standard 1.3.4.
24	78	F2005L0124626 May 2005FSC2026 May 2005	26 May 2005	rs	Heading of clause to include reference to electrolytes.
24(1), Table to s’clause 24(1)	78	F2005L0124626 May 2005FSC2026 May 2005	26 May 2005	rs	Amend subclause and Editorial note after the clause to treat potassium and sodium as electrolytes, rather than minerals.
27	99	F2008L0229726 June 2008FSC4126 June 2008	26 June 2008	rs	To clarify operation of the clause.
28	138	F2013L0005014 Jan 2013FSC8018 Jan 2013	18 Jan 2013	am	Consequential amendment relating to Standard 1.2.7.
32	72	F2008B0081924 Dec 2008FSC1420 May 2004	20 May 2004	rs	References for ‘cysteine’ amended to ‘cyst(e)ine’.
32(3)(a)	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	rs	‘Cyst(e)ine & methionine’ replaced with ‘cysteine, cystine and methionine’ and related consequential amendments.
32(4)	67	F2008B0081424 Dec 2008FSC931 July 2003	31 July 2003	am	Typographical error.
Table to, clause 32	103	F2008L037419 Oct 2008FSC459 Oct 2008	9 Oct 2008	rs, am	‘Cyst(e)ine & methionine’ replaced with ‘cysteine, cystine and methionine’ and related consequential amendments.
Table to clause 32	141	F2013L0081121 May 2013FSC8323 May 2013	23 May 2013	rs	Entry for histidine.
Sch 1	72	F2008B0081924 Dec 2008FSC1420 May 2004	20 May 2004	ad	Reference to sodium selenate.
Sch 1	88	F2006L032705 Oct 2006FSC305 Oct 2006	5 Oct 2006	rep	‘dehydrate’ from the listing for the permitted form of molybdenum.
Infant Formula Prods G’lines	105	F2009L0007615 Jan 2009FSC4715 Jan 2009	15 Jan 2009	rs	Guidelines
Infant Formula Prods G’lines	105	F2009L0007615 Jan 2009FSC4715 Jan 2009	15 Jan 2009	rep	Editorial note after the Guidelines after the table.
Infant Formula Prods G’lines	142	F2013L0146530 July 2013FSC841 Aug 2013	1 Aug 2013	rs	‘Inulin-derived substances’ replaced with ‘inulin-type fructans’ and consequential amendment to the Table of Provisions.

Amendment HistoryAmendment History

Get a plain-English read of Amendment History

Amendment History